SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-027550
Filing Date
2020-03-02
Accepted
2020-03-02 09:03:02
Documents
7
Period of Report
2020-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2011380d1_8k.htm 8-K 35449
2 EXHIBIT 4.1 tm2011380d1_ex4-1.htm EX-4.1 84404
3 EXHIBIT 5.1 tm2011380d1_ex5-1.htm EX-5.1 10669
4 EXHIBIT 10.1 tm2011380d1_ex10-1.htm EX-10.1 195737
5 EXHIBIT 99.1 tm2011380d1_ex99-1.htm EX-99.1 12391
6 GRAPHIC tm2011380d1_ex5-1img001.jpg GRAPHIC 4101
7 GRAPHIC tm2011380d1_ex99-1img001.jpg GRAPHIC 37785
  Complete submission text file 0001104659-20-027550.txt   398126
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 20674408
SIC: 2834 Pharmaceutical Preparations